Anne Arundel Medical Center in Maryland reduced opioid prescribing over a 16-month period by implementing interventions to educate prescribers, patients and the public about opioid risks and safety and promote clinician accountability, according to a study published Friday by JAMA Network Open. Monthly morphine milligram equivalents per encounter and MME per opioid prescription fell by 58 percent and 34 percent, respectively, compared with the average for the baseline period, while the opioid prescription rate fell by 38 percent. “Our data demonstrate that it is possible, through a coordinated, multilevel campaign, to reduce opioid overprescribing without worsening overall patient satisfaction,” the authors said. The AHA offers a toolkit to help hospitals and health systems work with their patients, clinicians and communities to tackle the opioid epidemic.

Related News Articles

Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…